Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Am J Hypertens ; 5(6 Pt 2): 147S-153S, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1321639

RESUMO

Thrombin-induced platelet aggregation is associated with an increase in intracellular calcium. Epinephrine provokes aggregation in the absence of a rise in intracellular calcium. Adenosine has been postulated as an endogenous inhibitor of platelet aggregation. In this study, the authors examine the effect of adenosine on the rise in intracellular calcium and on platelet aggregation, and the role of cyclic AMP (cAMP) in these actions. Human platelets were obtained from citrated plasma containing 5 micrograms/mL of indomethacin. Intracellular calcium was determined by fura-2 fluorescent dye. Adenosine inhibited thrombin-induced platelet aggregation and the rise in intracellular calcium in a dose-dependent manner. At a concentration of 100 mumol/L, adenosine completely inhibited thrombin-induced aggregation, but only partly inhibited the rise in intracellular calcium (55%). Adenosine also partially inhibited the rise in calcium produced by thrombin in both calcium-containing and calcium-free media, suggesting that adenosine inhibits both calcium influx and calcium mobilization. The effects of adenosine on intracellular calcium, as in the case of platelet aggregation, appear to be linked to adenylate cyclase, since they were prevented by the adenylate cyclase inhibitor 2',5'-dideoxyadenosine (1-mmol/L) and were potentiated by phospho-diesterase inhibition with papaverine (1 mumol/L). Adenosine and dibutyryl-cAMP also inhibited epinephrine-stimulated platelet aggregation in a dose-dependent manner. Thus, it appears that adenosine may inhibit platelet aggregation independently of its ability to decrease cytosolic free calcium.


Assuntos
Adenosina/farmacologia , Plaquetas/efeitos dos fármacos , Cálcio/sangue , AMP Cíclico/fisiologia , Epinefrina/farmacologia , Trombina/farmacologia , Plaquetas/química , Bucladesina/farmacologia , Cálcio/análise , Didesoxiadenosina/farmacologia , Relação Dose-Resposta a Droga , Fura-2 , Humanos , Indometacina/farmacologia , Papaverina/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Inibidores da Agregação Plaquetária/farmacologia
2.
Kardiologiia ; 31(11): 76-9, 1991 Nov.
Artigo em Russo | MEDLINE | ID: mdl-1666665

RESUMO

Adenosine inhibits platelet aggregation and elevates the levels of cytoplasmic Ca2+ induced by thrombin, 0.3 U/ml). When given at the maximal (100 microM) concentration, adenosine completely inhibits the aggregation, but only partially (by 55%) suppresses the growth of Ca2+, blocking both its entry and intracellular depot mobilization. Adenosine is likely to affect intracellular Ca2+, by activating adenylate cyclase, since 2',5'-didesoxyadenosine (1 mM) prevents the effect of adenosine, by inhibiting the enzyme, whereas the phosphodiesterase inhibitor papaverine (1 microM) potentiates its effect. When stimulated with adrenaline, 1 microM, adenosine and dibutyryl-cAMP are also able to inhibit platelet aggregation in the absence of cytoplasmic Ca2+ growth.


Assuntos
Adenosina/farmacologia , Cálcio/metabolismo , Citoplasma/efeitos dos fármacos , Inibidores da Agregação Plaquetária/farmacologia , Agregação Plaquetária/efeitos dos fármacos , AMP Cíclico/fisiologia , Citoplasma/metabolismo , Humanos , Técnicas In Vitro
3.
Biull Eksp Biol Med ; 111(5): 485-6, 1991 May.
Artigo em Russo | MEDLINE | ID: mdl-1878561

RESUMO

Using new-developed method of aggregates radius measurement in suppression of washed human platelets, it has been shown, that HDL, in concentration of 190 ug/ml and in higher ones, totally inhibited aggregation, induced by 0.075 U/ml thrombin. For the same effect on aggregation, induced by 0.225 U/ml thrombin, HDL in concentration of 1320 ug/ml were needed.


Assuntos
Lipoproteínas HDL/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Humanos , Lipoproteínas HDL/administração & dosagem , Inibidores da Agregação Plaquetária/farmacologia , Trombina/farmacologia
4.
Biokhimiia ; 55(12): 2255-60, 1990 Dec.
Artigo em Russo | MEDLINE | ID: mdl-2096954

RESUMO

Using calmodulin covalently labeled with dansyl, the Ca2(+)-dependent interaction of phosphorylase kinase with calmodulin has been studied. It has been shown that at pH 6.8 the (alpha beta gamma delta) protomer of the enzyme binds 2.1 +/- 0.8 mol of calmodulin with Kd = (6.67 +/- 1.77).10(-8) M. The enzyme activation induced by the pH increase up to 8.2 does not affect the enzyme interaction with calmodulin [2.14 +/- 0.58 mol calmodulin per mol of (alpha beta gamma delta)]; Kd = (4.14 +/- 1.22).10(-8) M. However, the enzyme activation during its autocatalytic phosphorylation eliminates this effect practically completely.


Assuntos
Calmodulina/metabolismo , Fosforilase Quinase/metabolismo , Animais , Catálise , Concentração de Íons de Hidrogênio , Fosforilação , Coelhos , Espectrometria de Fluorescência
5.
Biokhimiia ; 55(7): 1251-6, 1990 Jul.
Artigo em Russo | MEDLINE | ID: mdl-2223899

RESUMO

Using the binding of labeled [125I]troponin C (TnC) to troponin I (TnI) and troponin (TnT) immobilized on a polyvinylchloride matrix, the Ca-dependent formation of interprotein bonds in the cardiac troponin complex and the effects of various drugs on the above reaction were studied. It has been found that in the absence of Ca2+ the dissociation constant, Kd, for the TnC-TnI complex in equal to (2.5 +/- 1.03).10(-7) M. In the presence of Ca2+ the number of binding sites increases twofold; the Kd value for the bonds formed thereby is (1.74 +/- 0.18).10(-7) M. The complex is stable to the effect of 5 M urea. TnC binding to immobilized TnT is nonspecific and is completely abolished by an addition of 5 M urea. DPI 201-106 used at concentrations up to 10(-3) M does not affect the Ca-dependent binding of TnC to TnI; trifluoperazine inhibits this interaction by 60%, whereas substance 48/80 inhibits the reaction by 50% when used at a concentration of 210 micrograms/ml. It is supposed that the compounds interacting with TnC affect, primarily, the cation-binding properties of troponin. These compounds can also inhibit the formation of interprotein bonds but only when used at much higher concentrations.


Assuntos
Calmodulina/antagonistas & inibidores , Miocárdio/química , Piperazinas/farmacologia , Troponina/química , Animais , Bovinos , Coração/efeitos dos fármacos , Técnicas In Vitro , Cinética , Troponina/efeitos dos fármacos , Troponina C
6.
Biokhimiia ; 55(4): 754-9, 1990 Apr.
Artigo em Russo | MEDLINE | ID: mdl-2165822

RESUMO

The effects of Ca2+ antagonists (nicardipine, felodipine, nitrenedipine, isradipine, niphedipine, darodipine and riodipine) and Ca2+ agonists (BAY K8644 and CGP 28392), 1.4-dihydropyridine derivatives (1.2-DHP), on the calmodulin (CM)-dependent activation of cyclic nuxleotide phosphodiesterase (PDE) were studied. Both the blockers and activators of slow potential-dependent Ca2+ channels induced a un-competitive inhibition of the CM-dependent PDE activity. 1.4-DHP was found to replace the fluorescent probe, diS-C3-(5), from the Ca2(+)-dependent calmodulin-dye complex (K0.5 = 4-60 microM) but at concentrations below 100 microM had no effect on the Ca2(+)-dependent troponin C-dye complex. Darodipine (100 microM) did not interact with the proteins. The 1.4-DHP interaction with CM did not interfere with PDE activation. It is concluded that 1.4-DHP may affect Ca2+ dependent processes not only at the levels of activation or blocking of Ca2+ channels, but also through regulation of Ca2(+)-CM dependent enzymes.


Assuntos
2',3'-Nucleotídeo Cíclico Fosfodiesterases/metabolismo , Agonistas dos Canais de Cálcio/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Proteínas de Ligação ao Cálcio/metabolismo , 2',3'-Nucleotídeo Cíclico Fosfodiesterases/antagonistas & inibidores , Animais , Ligação Competitiva , Agonistas dos Canais de Cálcio/metabolismo , Bloqueadores dos Canais de Cálcio/metabolismo , Calmodulina/metabolismo , Bovinos , Ativação Enzimática , Técnicas In Vitro , Cinética , Coelhos , Troponina/metabolismo
7.
Biokhimiia ; 54(9): 1533-42, 1989 Sep.
Artigo em Russo | MEDLINE | ID: mdl-2556188

RESUMO

Using the intracellular Ca2+-specific indicator, Quin 2, it was demonstrated that an addition to platelet suspensions of the GTP-binding protein activator, sodium fluoride, stimulates the Ca2+ and Ba2+ influx from the incubation medium into the cytoplasm via receptor-operated Ca2+ channels (Ca-ROC). The fluoride-induced Ca2+ influx is blocked by the protein kinase C activator, phorbol myristate acetate as well as by the platelet adenylate cyclase activator, prostaglandin E1. A two-dimensional electrophoretic analysis of platelet phosphoproteins revealed that the phorbol ester enhances the phosphorylation of proteins with molecular masses of about 20 and 40 kDa. The experimental results suggest that the participation of the GTP-binding protein in the receptor coupling to Ca-ROC. The mechanism of the blocking effect of phorbol esters and prostaglandin E1 on Ca-ROC consists in an impaired coupling of these channels to the GTP-binding protein that activates them.


Assuntos
Canais de Cálcio/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Ésteres de Forbol/farmacologia , Plaquetas/metabolismo , Ativação Enzimática , Humanos , Técnicas In Vitro , Focalização Isoelétrica , Cinética , Fosforilação , Proteína Quinase C/metabolismo , Espectrometria de Fluorescência
8.
Biokhimiia ; 54(2): 265-72, 1989 Feb.
Artigo em Russo | MEDLINE | ID: mdl-2742925

RESUMO

Using a new methodological approach based on the binding of 125I-labeled troponin C to troponins I and T immobilized on polyvinylchloride, the Ca2+-dependent interaction of troponin components was investigated. In the absence of Ca2+, two types of sites of troponin C--troponin T interaction were revealed (Kd = 3.6.10(-8) M and 5.10(-7) M). It was found that Ca2+ induced the formation of a troponin I--troponin C complex which was resistant to 5 M urea (Kd = 4.10(-8) M). In the absence of Ca2+, the binary troponin T--troponin C complex also revealed two types of interaction sites (Kd = 7.1.10(-8) M and 2.10(-7) M); however, in the presence of Ca2+ only high affinity sites whose number increased almost 2-fold were revealed. The events that may take place in the whole troponin complex during Ca2+ binding by troponin C are discussed.


Assuntos
Cálcio/farmacologia , Músculos/efeitos dos fármacos , Troponina/metabolismo , Animais , Benzotiazóis , Ligação Competitiva , Carbocianinas , Corantes Fluorescentes , Técnicas In Vitro , Músculos/metabolismo , Cloreto de Polivinila , Coelhos , Troponina C , Troponina I , Troponina T , Ureia
9.
Arzneimittelforschung ; 37(9): 1013-7, 1987 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2449225

RESUMO

The interaction of several phenothiazines, benzodiazepines, butyrophenones, polycyclic neuroleptics and tricyclic antidepressants with calmodulin and troponin C was investigated using the fluorescent dye 3,3'-dipropylthiocarbocyanine iodide. In the presence of Ca2+, trifluoperazine (2-trifluoromethyl-10-[3-(1-methylpiperazinyl-4)propyl]-phenothiaz ine dihydrochloride, TFP), which is commonly used as a selective calmodulin inhibitor, half maximally increased the fluorescence of the complex formed of the fluorescent dye with calmodulin at a concentration of 4 mumol/l, and with troponin C at 24 mumol/l. TFP completely inhibited the calmodulin dependent stimulation of cyclic nucleotide phosphodiesterase with a Ki of 4 mumol/l and decreased the maximum Ca2+ dependent troponin C mediated activation of actomyosin ATPase by 35% at a concentration of 100 mumol/l. Metofenazate (3,4,5-trimethoxybenzoate-2-chlor-10-(3-[(beta-oxyethyl) piperazinyl-4]-propyl)phenothiazine diethanesulfonate, methophenazine, MP) produced half maximal fluorescence enhancement of the calmodulin dye complex at a concentration of 6 mumol/l and did not influence the fluorescence of the troponin C dye complex at concentrations of up to 1000 mumol/l. MP also completely inhibited the calmodulin dependent stimulation of phosphodiesterase with a Ki of 7 mumol/l but it had not effect on maximum Ca2+ stimulation of actomyosin ATPase. MP increased the Ca2+ sensitivity of skinned cardiac muscle with an about 10fold lower potency than TFP. In view of these results, we propose MP as a useful tool for distinction between processes mediated by either calmodulin or troponin C.


Assuntos
Antipsicóticos/farmacologia , Calmodulina/antagonistas & inibidores , Fenotiazinas/farmacologia , Trifluoperazina/farmacologia , 3',5'-AMP Cíclico Fosfodiesterases/metabolismo , Actomiosina/metabolismo , Adenosina Trifosfatases/antagonistas & inibidores , Animais , Butaclamol/farmacologia , Nucleotídeo Cíclico Fosfodiesterase do Tipo 1 , Técnicas In Vitro , Miocárdio/metabolismo , Coelhos , Espectrometria de Fluorescência , Suínos , Troponina/metabolismo
10.
Vopr Med Khim ; 33(2): 27-31, 1987.
Artigo em Russo | MEDLINE | ID: mdl-3037792

RESUMO

Calmodulin-dependent regulation of cyclic nucleotide phosphodiesterase and kinase phosphorylase activities as well as Ca2+-dependent regulation of kinase phosphorylase, mediated via the integrated calmodulin, were studied in presence of phenothiazine and butyrophenone series of pharmacological drugs. As compared with butyrophenones, phenothiazines were shown to be more effective inhibitors of calmodulin-dependent activation of the phosphodiesterase. Phenothiazines inhibited similarly the effect of calmodulin on activity of kinase phosphorylase, whereas they did not affect the Ca2+-dependent activity of kinase phosphorylase. At the same time, butyrophenones proved to inhibit the Ca2+-dependent activation of kinase phosphorylase, mediated via integrated calmodulin as well as these drugs inhibited uniformly the calmodulin-dependent regulation of both kinase phosphorylase and phosphodiesterase. The data obtained suggest that dissimilar effect of phenothiazines on calmodulin-dependent regulation of kinase phosphorylase and phosphodiesterase, carried out using dissimilar mechanisms, required an extreme caution in evaluation of physiological and biochemical experiments, where these drugs were used as means for study of calmodulin functions in biological processes.


Assuntos
3',5'-AMP Cíclico Fosfodiesterases/metabolismo , Calmodulina/metabolismo , Fosforilase Quinase/metabolismo , Animais , Sítios de Ligação , Nucleotídeo Cíclico Fosfodiesterase do Tipo 1 , Depressão Química , Técnicas In Vitro , Cinética , Músculos/enzimologia , Miocárdio/enzimologia , Inibidores de Fosfodiesterase , Fosforilase Quinase/antagonistas & inibidores , Coelhos
11.
Biomed Biochim Acta ; 46(8-9): S440-3, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-2449186

RESUMO

In this study, ligands from various chemical classes were investigated with respect to their relative affinities to calmodulin (CaM) and troponin C (TnC), using the fluorescent dye 3,3'-dipropylthiocarbocyanine iodide (diS-C3-5'). In parallel, functional tests were carried out determining the effects of the ligands on the CaM activated cyclic nucleotide phosphodiesterase (PDE) activity and the TnC mediated Ca-sensitivity of skinned myocardial fibres and cardiac myofibrils. The following results were obtained: 1) As a rule, most of the ligands tested had higher affinities to CaM than to TnC. 2) Even within one and the same pharmacological class (e.g. phenothiazines) the relative affinities for CaM and TnC varied considerably, trifluoperazine (TFP) or levomepromazine (LMP) showing low or no CaM specificity, methophenazine (MP) on the other hand being highly selective for CaM by a factor of more than 200. 3) In all cases tested, the functional tests were in good quantitative agreement with the binding data, showing inhibition of CaM stimulated PDE activity and Ca-sensitizing effects in concentrations corresponding well with the respective drug affinities to CaM and TnC, respectively. 4) It is concluded that a) interaction of ligands with TnC can lead to Ca-sensitization of the cardiac contractile system and a positive inotropic effect without a concomitant elevation of the intracellular level of activator Ca. This may result in a novel cardiotonic principle avoiding the common side effects of 'classical' positive inotropic agents due to Ca-overload. b) drug selectivity for TnC or CaM appears chemically achievable.


Assuntos
Calmodulina/metabolismo , Troponina/metabolismo , Animais , Benzodiazepinonas/farmacocinética , Benzodiazepinonas/farmacologia , Butaclamol/farmacocinética , Butaclamol/farmacologia , Cálcio/metabolismo , Técnicas In Vitro , Miocárdio/metabolismo , Fenotiazinas/farmacocinética , Fenotiazinas/farmacologia , Suínos , Troponina C
13.
Biokhimiia ; 50(7): 1141-50, 1985 Jul.
Artigo em Russo | MEDLINE | ID: mdl-2864085

RESUMO

The effects of neurotropic compounds on Ca-binding proteins (calmodulin, troponin C) were investigated. It was shown that the majority of neuroleptics of the phenothiazine group effectively interact with the both proteins and inhibit calmodulin-dependent cyclic nucleotide phosphodiesterase and Ca2+-activated actomyosin. ATPase. Neuroleptics of the butyrophenone group as well as imipramine and diphenehydramine having a low efficiency interact only with calmodulin. Methophenazine, a phenothiazine neuroleptic, being an effective inhibitor of calmodulin and of calmodulin-dependent phosphodiesterase, does not influence troponin C or Ca-dependent actomyosin ATPase. Therefore, this compound may be used as a convenient tool in the study of processes controlled by these Ca-binding proteins. It is concluded that troponin C possesses Ca-dependent sites which bind pharmacological agents structurally similar to that of calmodulin. However, these sites bind pharmacological agents with a low efficiency and exhibit selectivity towards certain drugs. Despite the obvious homology of the both Ca-binding proteins, i.e., calmodulin, troponin C, their effects on the processes under their control appear to be selective.


Assuntos
Antipsicóticos/farmacologia , Calmodulina/metabolismo , Troponina/metabolismo , 3',5'-AMP Cíclico Fosfodiesterases/antagonistas & inibidores , Animais , Antipsicóticos/metabolismo , Encéfalo/enzimologia , Calmodulina/antagonistas & inibidores , Nucleotídeo Cíclico Fosfodiesterase do Tipo 1 , Corantes Fluorescentes , Técnicas In Vitro , Fenotiazinas/metabolismo , Fenotiazinas/farmacologia , Coelhos , Troponina/antagonistas & inibidores , Troponina C
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA